Abishek Saravanan: Neuroprotective Benefits of Sovateltide in Real-World Stroke Management
Abishek Saravanan, Pharmacist Executive at Parekh Integrated Services Pvt. Ltd., shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Publication Announcement | Research Milestone Achieved
I am delighted to share that our research article titled:
Real-world functional outcomes of sovateltide as an adjunct to standard therapy in acute ischemic stroke: A prospective observational study’ has been successfully published in Medicine (journal) (Vol. 105, Issue 8, 2026).
This study evaluates the real-world effectiveness of sovateltide as an adjunct therapy in patients with acute ischemic stroke, focusing on functional recovery and neurological outcomes when combined with standard stroke management.
Key Highlights:
- Prospective observational evaluation in patients with acute ischemic stroke
- Assessment of functional recovery outcomes with adjunct sovateltide therapy
- Real-world clinical evidence supporting neuroprotective strategies in stroke management
- Contribution to the growing research on novel therapeutic approaches for improving stroke recovery
I sincerely thank all my co-authors, mentors, and collaborators for their valuable guidance and support throughout this research work.
This publication represents another step forward in advancing clinical research in neurology and pharmacy practice.”
Title: Real-world functional outcomes of sovateltide as an adjunct to standard therapy in acute ischemic stroke: A prospective observational study
Authors: Geetha Kandasamy, Lavanya Selvaraj, Khalid Orayj, Mona Almanasef, Amjad Hmlan, Rayah Asiri, Afaf Ahmed Aldahish, Vasudevan Mani, Abishek M Saravanan, Kousalya Prabahar
Read the Full Article on Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion
-
Sep 16, 2026, 13:21Sophia Delicou: Mediterranean Network for Haemoglobinopathies and Regional Collaboration
-
Sep 16, 2026, 13:11New Clinical Guidelines for Iron Deficiency from ASH
-
Sep 16, 2026, 13:03Khushboo Lakhera: Sharing One Purpose with Blood Donation Camp
-
Sep 16, 2026, 11:05May AlMoshary: A Decade of Iron Deficiency and Anemia Data From Saudi Arabia
-
Sep 16, 2026, 10:47Rick Matthews: Cancer-Associated VTE Mortality and the Need for Coordinated Care